Spine BioPharma
Spine Biopharma has developed a non-surgical solution for those struggling with debilitating back pain.
Launch date
Employees
Market cap
-
Enterprise valuation
€59m (Public information from Oct 2023)
New York City New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.0m | Series A | ||
* | $13.0m | Series B | |
* | N/A | $13.0m | Debt |
* | N/A | $480k | Debt |
* | N/A | $1.9m Valuation: $65.0m | Late VC |
| Total Funding | €18.1m | ||